Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer's disease
Nicholas C. Cullen
, Shorena Janelidze
, Erik Stomrud
,
Randall J. Bateman
, Sebastian Palmqvist
, Oskar Hansson
, Niklas Mattsson-Carlgren
Department of Neurology
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
DBBS - Biomedical Informatics and Data Science
DBBS - Neurosciences
Hope Center for Neurological Disorders
Institute of Clinical and Translational Sciences (ICTS)
Research output
:
Contribution to journal
›
Article
›
peer-review
10
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer's disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alzheimer's Disease
100%
Apolipoprotein E
100%
Pre-screening
100%
Secondary Prevention Trials
100%
Plasma Amyloid-β
100%
Amyloid PET
100%
Cognitively Unimpaired
37%
Biomarker Model
25%
Cost Ratio
25%
Recruitment Costs
25%
High Risk
12%
Cost Reduction
12%
Blood Biomarkers
12%
Alzheimer
12%
Plasma Biomarkers
12%
BioFINDER
12%
Screening Cost
12%
Total Saving
12%
Plasma Screening
12%
Neuroscience
Alzheimer's Disease
100%
Apolipoprotein E
100%
Positron Emission Tomography
100%
Amyloid Protein
100%
Blood Plasma
100%
Positron Emission Tomography
18%
Immunology and Microbiology
Blood Plasma
100%
Apolipoprotein E
100%
Positron Emission Tomography
28%